Literature DB >> 21122536

A United Kingdom inflammatory bowel disease database: making the effort worthwhile.

K D Bardhan1, N Simmonds, C Royston, A Dhar, C M Edwards.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD), a paradigm of chronic illness, requires for its safe clinical management ready access to complete information, not always possible using paper records. AIM: To develop an IBD database (DB) for both individual patient management and collating information across centres.
METHODS: Access® based, with a minimum dataset.
RESULTS: Prospectively collected data for 11,432 patients from 21 centres. PROFILE DIAGNOSIS: Ulcerative colitis (UC) 56%, Crohn's disease (CD) 40%, indeterminate colitis 4%. M:F ratio: UC 1.08:1, CD 0.72:1. Median age at diagnosis: UC 39, CD 30 years. Operated: UC 16%, CD 47%. Thiopurine use: UC 16%, CD 29%. IBD related mortality: 0.74%. DISCUSSION: A snapshot of this large IBD cohort shows the disease profile across the UK is similar to other large series. Unexpected gaps, sometimes large emerged (e.g. data on smoking and immunosuppression) highlighting the need for clear definition, consistency and completeness of data collection. Clinical management is made easier by the 'at a glance' summary, automated clinic letters, and facility for monitoring and audit, but the time required limited its 'real-time' use.
CONCLUSION: Our experience shows it is possible to collect data from centres across the country which truly reflects clinical practice. We have learned as much from the process itself as from the data, principally, information needs to be well defined, validated at entry, and updated at every visit, a time consuming sequence which we had underestimated. Our lessons learned may help inform the development of a national database, and support national IBD standards and audit.
Copyright © 2010 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21122536     DOI: 10.1016/j.crohns.2010.01.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  8 in total

1.  Self-Reported Medication Adherence Among Patients with Ulcerative Colitis in Japan and the United Kingdom: A Secondary Analysis for Cross-Cultural Comparison.

Authors:  Aki Kawakami; Makoto Tanaka; Lee Meng Choong; Reiko Kunisaki; Shin Maeda; Ingvar Bjarnason; Bu'Hussain Hayee
Journal:  Patient Prefer Adherence       Date:  2022-03-08       Impact factor: 2.711

2.  Daily life difficulties among patients with ulcerative colitis in Japan and the United Kingdom: A comparative study.

Authors:  Aki Kawakami; Makoto Tanaka; Kayoko Sakagami; Lee Meng Choong; Reiko Kunisaki; Shin Maeda; Ingvar Bjarnason; Hiroaki Ito; Bu'Hussain Hayee
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

3.  Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases.

Authors:  Mohammad A Al-Mofarreh; Ibrahim A Al-Mofleh
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

Review 4.  Epidemiology of inflammatory bowel diseases in iran and Asia; a mini review.

Authors:  Ali Reza Safarpour; Seyed Vahid Hosseini; Davood Mehrabani
Journal:  Iran J Med Sci       Date:  2013-06

5.  IBDsite: a Galaxy-interacting, integrative database for supporting inflammatory bowel disease high throughput data analysis.

Authors:  I Merelli; F Viti; L Milanesi
Journal:  BMC Bioinformatics       Date:  2012-09-07       Impact factor: 3.169

6.  Changing nationwide trends in endoscopic, medical and surgical admissions for inflammatory bowel disease: 2003-2013.

Authors:  Ahmir Ahmad; Anthony A Laverty; Chris Alexakis; Tom Cowling; Sonia Saxena; Azeem Majeed; Richard C G Pollok
Journal:  BMJ Open Gastroenterol       Date:  2018-03-20

7.  Economic analysis of the adoption of capsule endoscopy within the British NHS.

Authors:  Alan Lobo; Rafael Torrejon Torres; Mark McAlindon; Simon Panter; Catherine Leonard; Nancy van Lent; Rhodri Saunders
Journal:  Int J Qual Health Care       Date:  2020-06-17       Impact factor: 2.038

8.  Cognitive-behavioural therapy for the management of inflammatory bowel disease-fatigue: a feasibility randomised controlled trial.

Authors:  Micol Artom; Wladyslawa Czuber-Dochan; Jackie Sturt; Hannah Proudfoot; Danniella Roberts; Christine Norton
Journal:  Pilot Feasibility Stud       Date:  2019-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.